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INTRODUCTION

Previous in vivo studies have demonstrated profound increases in plasma
catecholamines (CA) in response to intravenous administration of bacterial endotoxin [1,
2, 3, 4]. Additional evidence suggests that such changes are due to non-neurogenic as
well as an enhanced neurogenic release of epinephrine (Epi) from the adrenal medulla
[5, 6, 7]. These reports imply that in response to septic insult, mechanisms appear to
be activated to cause enhanced release of medullary catecholamines and thus, elevate the
functional sympathetic output.
The immune system is at the forefront of whole animal defense mechanisms that
are mobilized against septic challenge. One of the key immune responses to endotoxin
is the production of cytokines, a class of inducible, water-soluble, heterogeneous
proteinaceous mediators with molecular weights above 5000 kD. Cytokines are secreted
mainly by cells of the mononuclear phagocyte system. Interleukin-I (IL-1), Tumor
Necrosis Factor (TNF), Interleukin-6 (IL-6) and some others are all known to be
produced following the i. v. administration of bacterial endotoxin in experimental animals
[8, 9]. Furthermore, the immune and neuroendocrine systems appear to communicate
with each other by common signal molecules (i.e. cytokines) and receptors [10]. A
growing body of evidence has shown that cytokines can act on neuroendocrine tissues,
such as some areas of hypothalamus, pituitary, and adrenal cortex, etc [11, 12, 13].
The present study was designed to examine the possibility that the molecules (e.g.
cytokines) produced by activated immunocompetent cells, are capable of modulating
catecholamine secretion from chromaffin cells.

To test this possibility, in vitro
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experimental systems were used.

Isolated bovine splenocytes were stimulated with

mitogen to obtain cytokine-rich media which was then tested on the primary culture of
bovine chromaffin cells (BCC). The experimental approach included three steps: 1)
characterizing the chromaffin cell model in terms of functional changes (i.e. secretion)
over days in culture; 2) using conditioned media, obtained from mitogen-stimulated
bovine splenocyte culture, to demonstrate the possible role played by cytokines in
modulating chromaffin cell secretion; and 3) examining whether the catecholamine
release, induced by the conditioned media, is due to elevated exocytotic activity or
damage of the cell membrane.
The results of this study demonstrate that immune-derived products from mitogenactivated splenocytes stimulate CA secretion from cultured BCC and enhance the
nicotinic agonist induced release. This CA release does not appear to be related to cell
membrane damage.

REVIEW OF THE RELATED LITERATURE

I.

Sympathetic Activation in Septic Shock.
Sympathetic hyperactivity has been implicated in the pathogenesis of endotoxin

(ET) shock [14].

In experimental models of ET shock, increased circulating

catecholamines (CA) [1, 2, 3, 4], increased norepinephrine (NE) turnover rate in heart
and spleen tissues [15] and depletion of CA content in sympathetically innervated organs
at the end stage of shock [16, 17, 18] have been demonstrated.

These findings are

interpreted as evidence for increased CA release from both sympathetic nerve terminals
and the adrenal medulla, and are considered to be directly related to increased
sympathetic nerve activity from the central nervous system. Recent studies, however,
suggest the existence of non-neurogenic stimulation of adrenal CA release following ET
administration. In conscious adrenal denervated animals, plasma epinephrine (Epi) was
elevated at 90 min post ET, although the amplitude was about one third of that observed
in control rats given ET [6]. In addition, other experiments have shown that ganglionic
blockade could not prevent the stimulation of adrenomedullary secretion during
endotoxicosis [5]. In vitro incubation of adrenal chromaffin cells with endotoxin or
endotoxin-elaborated agents, such as bradykinin, histamine and prostaglandins, resulted
in CA secretion [19, 10, 21, 22]. These findings imply that adrenal CA secretion may
be due in part to non-neurogenic mechanism. The cellular mechanisms mediating this
non-neurogenic CA efflux remain largely unexplored.
A wide range of responses occur when ET interacts with mammalian host
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defenses.

In an older view, histamine, arachidonic acid metabolites and vasoactive

peptides have been considered to be major mediators responsible for various
pathophysiologic responses during endotoxin shock [23].

In addition, it has been

generally accepted that circulatory hypodynamic responses to ET activate autonomic
reflex adjustments with a concomitant increase in CA release from adrenal glands [23].
This response would tend to compensate for the early hypotensive effects of ET and
improve perfusion pressure and circulation to vital organs. The efflux of CA, especially
Epi, from adrenal medulla may be caused not only by the acceleration of efferent impulse
traffic over sympathetic nerve pathways but also by the direct interaction of certain
humeral factors with medullary chromaffin cells. The influence of humeral factors is
supported by the presence of various receptors on bovine chromaffin cell membrane.
Besides the nicotinic and muscarinic receptors, chromaffin cells possess histamine Hl,
prostaglandin E-2 (PGE2), vasoactive intestinal peptide (VIP), angiotensin II, atrial
natriuretic peptide (ANP), bradykinin, endothelin, insulin-like growth factor 1 (IGFl) and
ATP receptors, which have stimulatory effect on CA secretion upon binding to their
agonists [24].

Therefore, ET-elaborated factors such as histamine, PG and some

vasoactive peptides may play a role in non-neurogenic CA secretion from adrenal
medulla in the course of developing septic shock.

II.

Cytokines as the Mediators of Septic Shock.
The diverse spectrum of mediators elicited by ET leads to the complexity of

biological responses [25]. Many effects of ET apparently result from its interaction with
various components of host immune system. In particular, immune-derived cytokines
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have attracted much attention in studies of the pathogenesis of gram-negative bacterial
infection. Cytokines are a heterogeneous group of peptides that help sustain, amplify and
regulate the cellular immune and inflammatory response to local infection [26]. They
have endocrine, paracrine and autocrine roles in the inflammatory response and mediate
changes that resemble aspects of the sepsis syndrome [27]. Monocytes release cytokines
in response to appropriate stimuli, and the hormone-like secretory products diffuse to
target cells, affecting their cellular activity. When the target cell is in the immediate
vicinity, a paracrine function is invoked, whereas when the target cell is reached via the
blood stream, the function becomes endocrine. At certain concentrations cytokine actions
are protective, but their overproduction can cause deleterious changes in organs or
tissues, in some cases resulting in death. Cytokines function as endogenous mediators
of immunological, metabolic and physiological alterations during bacterial infections,
which include inflammatory response, fever, metabolic and vascular changes, increased
energy expenditure, anorexia and shock. Although the precise knowledge of the initial
biochemical events after the bacterial invasion is not well established, much new
information has emerged in the past five years.
A.

Induction of Cytokine Expression by LPS.
The expression of cytokines appears to be tightly regulated. Little transcription

of the cytokine genes takes place under normal conditions. A specific stimulus, bacterial
or viral insult for instance, is usually required for induction of cytokine genes.
Endotoxin, a component of the gram-negative bacterial cell wall, is composed of a
polysaccharide portion and a lipid moiety called lipid A, and is generally referred to as
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lipopolysaccharide (LPS).

Biological analysis of the synthesized compounds has

confirmed that lipid A is the active center of LPS [28]. Due to its amphipathic nature,
LPS is able to interact with mammalian cell membrane nonspecifically by imbedding
itself into phospholipid bilayer.

Although such nonspecific interaction has been

documented with a variety of cell types, the actual relevance to the cellular response
remains to be determined. There is now strong experimental evidence to support the
concept that specific receptors for lipid A do exist and are functional on mammalian
lymphoreticular cells. For example, LPS of E. coli is able to stimulate TNF secretion
from macrophages, while the nontoxic LPS of Rhodoppseudomonas sphaeroides was
shown to block this production in a concentration-dependent manner [29]. Since the
structure of lipid A from the nontoxic LPS is quite similar to that of its counterpart of
E. coli LPS, the action of the non-toxic LPS is most likely explained by competitive

binding to the specific receptors for lipid A. Similar phenomena were also observed in
human monocytes [30] and neutrophils [31].
Morrison and colleagues have used a cross-linking approach to identify potential
LPS receptors [32]. CD14, a 55-kD glycoprotein held on the mononuclear cells surface
by a phosphotidylinostiol glycan anchor, has been identified as a receptor for LPS [33].
In fact, this receptor was able to recognize LPS only if it was complexed to LPS-binding
protein (LBP) [33].

LBP is a serum protein synthesized in liver as an acute phase

reactant [34]. LBP serves as an opsonin by binding stably to gram-negative bacteria
[35]. The ligated CD14 may trigger the synthesis and secretion of cytokines including
TNFa and IL-1 [36, 27]. The signal transduction pathway coupling stimulus-secretion
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is unclear. It has been suggested that microtubule-associated protein may be involved,
because taxol, a microtubule-disturbing agent could mimic cellular responses to LPS
[37]. It is conceivable that LPS could affect the cell function by altering the activities
of microtubule-associated kinases or phosphatases.
TNFa and IL-1 are produced in the early phases of sepsis [38]. IL-1 can regulate
T cells and induces the production of IL-2 [39]. BothTNFa and IL-1 are able to induce
the expression of IL-6 in monocytes, endothelial cells and fibroblasts [38, 40]. Despite
the fact that TNFa, IL-1 and IL-6 are predominant in sepsis, other cytokines such as IL8 and interferons (IFN) are also released as a sequel to endotoxemia [41, 42]. IFN-y is
produced

by

lymphocytes

following

antigenic

or

mitogenic

stimulation.

Monocytes/macrophages are involved in the induction of IFN-y synthesis via IL-1. IL-1
probably stimulates T-cell IL-2 secretion, and IL-2 may in turn induce IFN-y release [43].
Mice infected with Gram-negative bacterial exhibited a transient increase if IFN-y in
plasma between 2-4 days after infection.

Spleen cells explanted from infected mice

produced in vitro IFN-y spontaneously; this production was enhanced considerably by
LPS or concanavalin A [44].
B.

Cytokine Mediated Responses in Endotoxicosis.
TNFa, originally named cachectin, is a primary mediator in the pathogenesis of

infection [27, 45]. Studies of genetic tolerance to endotoxins led to the identification of
macrophage products as mediators of the physiological in response to bacterial infection.
Monocytes from the C3H/HeJ strain of mice are not responsive to several bacterial
endotoxins [46].

Their non-responsiveness results from a defect in LPS-mediated
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activation of their macrophages. Macrophages isolated from LPS-resistant mice do not
produce TNFa in response to LPS, while those from LPS responders exhibit high levels
of TNFa secretion [47]. When serum from an endotoxin-sensitive mouse (C3H/HeN
strain) is injected into a resistant mouse, it reproduces the changes induced in the
sensitive mouse by endotoxin [48]. This observation led to the identification and later
isolation of cachectin [49]. Experimental administration of bacterial endotoxin to human
volunteers leads to a marked increase of TNFa in the plasma at 90 minutes [8]. the
extent of symptoms, changes in white cells count, and production of ACTH were
temporally related to the peak concentration of TNFa. Infusion of recombinant human

TNFa into experimental animals produces effects similar to those manifested in Gramnegative sepsis [50]. Elevated plasma catecholamines have been observed as one of the
evident responses to i.v. injection of TNFa in rats [51], indicating that the
neuroendocrine function of sympathetic nerve and adrenal gland may be affected by TNF
or TNF associated events. Passive immunization with various anti-TNFa antibodies
protects the host from deleterious effects of both lethal and sublethal doses on endotoxin
[52]. These results illustrate that TNFa is an important mediator of pathophysiological
alterations characteristic of sepsis syndrome. Although antibodies against TNFa reduce
its effect, they do not completely abrogate the alterations induced by endotoxin [52].
This suggests that other endogenous factors may be involved.
TNFa can induce the production of IL-1 and vice versa; thus using in vivo
experimental models, it is impossible to determine whether the actions of TNFa or IL-1
are primary or secondary [53]. IL-1, which has many biological activities similar to
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TNFa, has been shown to induce a shock-like state in synergism with TNF in rabbits
[54]. The two classic activities associated with IL-1 are fever production and lymphocyte
activation, which have been confirmed by using a well-defined recombinant form of
human IL-1 [55].

Other activities include promoting coagulation and enhancing the

hepatic production of acute phase proteins [25].
Another important inductor of the acute phase _protein synthesis is IL-6, which is
closely related to the inflammatory response. In the lethal baboon E. coli shock model,
IL-6 was detectable within two hours post bacterial infusion, and steadily increased
during the first 8 hours [56]. In patients with meningococcal infections, IL-6 levels have
been associated with fatality [57].
Other cytokines, such as IFN')' and IL-8, were also detected in severe septic states
[38, 9], but their exact roles are unclarified. Macrophages from rats pretreated in vivo
with recombinant IFNI', released higher amounts of TNFa in response to LPS than the
control group did [58].

IL-1 expression induced by ET was also subject to the

modification of IFN')'. LPS stimulated about a four-fold increase in IL-1 mRNA in the
human monocyte cell line preincubated with IFNI' [59]. These results provide evidence
that IFN')' may be involved in the development of septic syndromes at least through its
action on macrophages. Collectively, cytokines play a key role in gram-negative sepsis
or shock and they are part of the immune response in all vertebrates [38, 6].
C.

Cellular Mechanisms of Cytokine Actions.
Cytokines, like hormones, exercise their effects at extremely low concentrations

via cell receptors [43]. An individual cytokine interacts in a highly specific manner with
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its cell receptor. All cytokine receptors are transmembrane glycoproteins made up of an
extracellular amino-terminal ligand binding domain, a short hydrophobic transmembrane
region and a carboxy-terminal intracellular domain.

Signal transmission across the

plasma membrane to activate the functional domain of the receptor is poorly understood.
The means by which cytokine-receptor interact with intracellular signalling pathways also
remain to be elucidated. However, there is experimental work that strongly implicates
the requirement for calcium ions, high-energy nucleotide intermediates (e.g. GTP, cAMP
and phospholipid derivatives, etc.) and protein kinases and phosphatases in the
transmitting process [61, 62]. At present, at least two signal transduction pathways have
been described that appear to be related to hormone- or cytokine-mediated cell responses
[60].

One of these involves G-protein, adenylate cyclase, protein kinase A and

calmodulin. In the other pathway, the receptor molecules themselves contain a tyrosine
kinase which, when activated, subsequently stimulates phospholipase C (PLC), possibly
also through G protein intermediates. Plasma membrane inositol phospholipids are then
broken down by PLC into inositol triphosphate and diacylglycerol which are active
intermediates for intracellular Ca2 + release and protein kinase C (PKC) activation,
respectively. PKC has a number of potential protein substrates, thus it can alter many
intracellular functions.
Intracellular events associated with the binding of TNFa to its receptor include
the phosphorylation of tyrosine residues on a stress protein [63] and on the epidermal
growth factor receptor [64]. Protein phosphorylation suggests an early effect on protein
kinases involved in signal transduction. A transient increase in cAMP after the activation
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of both TNFa and IL-1 receptors [65] has been reported. The interaction of IL-6 with
its receptor has not been found to induce any known conventional biochemical processes,
such as protein phosphorylation, phosphatidylinositol turnover or intracellular Ca2 +
increase. A novel transducer protein may be involved in the event immediately after
ligand-binding [66].
IFN')' receptors are single chain glycoproteins _that bind ligand with high affinity
in a species specific manner [67].

There appears to be only a single type of IFN')'

receptor that is expressed on nearly all cell types. Considerable data indicates that IFN')'
induces cellular responses via Ca2 + and possible protein kinase C-dependent mechanisms
[68, 69, 70]. Exposure of murine and human macrophage populations to the combination
of a protein kinase C activator and a calcium ionophore leads to the induction of many
of the same cellular responses as are induced by IFN')'. Calcium influx has also been
observed on cells exposed to IFN')' with 45 CaC1 2 [70]. An inhibitor of intracellular Ca2 +
release from endoplasmic reticulum was not able to block the cell response to IFN')',
while depletion of calcium from culture medium by EGTA could. These results suggest
an existence of receptor-mediated calcium channel.

ID.

Neuroendocrine-immune Interactions.
From research conducted over the past 10 years, complex interrelationships

among neural, endocrine and immune processes have become apparent [10].
Neuroendocrine and immune systems are intimately linked and communicate with each
other through the use of common signal molecules and receptors [71]. During the course
of an immune response hormonal changes occur [72]. Conversely, the activation of the
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neuroendocrine system during stress leads to changes in immune function, such as
inhibition of the production and action of several cytokines [73, 74]. These findings
provide the basis for the interesting concept that the immune system may serve as a
sensory organ [11, 75], which recognize non-self or altered-self antigens.

The

recognition of such stimuli is consequently converted into the form of cytokines and other
messengers which can be received by neuroendocrine_tissues [76] and thus, to induce an
integrative reaction.
Corticotropin (ACTH) was the first de novo synthesized hormone to be found in
the immune system by J.E. Blalock, et al. [77].

ACTH is a 39-amino acid peptide

whose production is primarily associated with the pituitary gland and whose classical
action is to elicit a glucocorticoid response from the adrenal cortex during times of stress.
Human peripheral blood lymphocytes and mouse spleen cells were initially observed to
express an ACTH-like peptide following virus infection or interaction with bacterial LPS
[42, 78].

Consistent with this observation has been the work of Besedovsky and

colleagues. They found that blood levels of glucocorticoids increase at the time of peak
immune response to several antigens [72].

Similar to that observed in immunized

animals, injection of lymphokine-containing supernatants from concanavalin A-activated
spleen cells could mimic the events occurring after antigen injection [79]. Such increases
were attributed in part to IL-1 [13, 80] and IL-2 [81] instead of immune-derived ACTHlike peptide. As soon as cytokines became available in pure form, they were tested
individually.

Intraperitoneal administration of recombinant IL-1 in rats elicited an

increased CRF (corticotropin releasing factor) secretion and a slight elevation of plasma
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Epi and NE levels [13]. IL-1 may work at any level of the hypothalamo-pituitary-adrenal
(HP A) axis. Although it is clear that IL-1 induced HPA activation involves an increased

secretion of CRF from hypothalamus [82, 83, 84], effects of IL-1 on hormone release
from pituitary [85, 86] and adrenal cortex [87, 88] have also been demonstrated.
Besides IL-1, such cytokines as IL-2, IL-6 and TNF were also found to activate
the HPA [89, 90, 91, 92], but they are less potent and less persistent [12]. IL-6 and
ACTH have been demonstrated to act synergistically to stimulate the release of
corticosterone from adrenal gland cells [93] in culture.

These observations clearly

illustrate that cytokines play an important role in mediating immune-neuroendocrine
communication.
Unlike classical hormones whose receptors are generally restricted in certain
tissues, cytokine receptors can be found in virtually all cell types [61]. Specific antiinterleukin receptor monoclonal antibodies can block the behavioral, brain electrical
activity and body temperature changes induced by microinfusion of IL-1, IL-2 and IL-3
in the rat brain [94]. Therefore, these interleukin-caused effects are most likely receptor-

mediated. Recent studies with radiolabeled IL-1 have shown that there are high-affinity
binding sites for IL-1 in certain areas of rodent brain [95, 96, 97]. IL-2 receptors have
been identified in human brain under pathological conditions [98]. The expression of IL2 receptors on pituitary cells was also detected by the monoclonal antibody-binding and
by electrophoretic analysis [99].

Structurally, the interferons (IFNs) resemble

glycoprotein hormones both in composition and approximate size [100]. Virtually all
nucleated cells within a species are sensitive to that species IFN and presumably possess
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IFN receptors [101]. Collectively, the presence of interleukins receptors in the CNS and
pituitary [102 , 103, 104, 105] is supportive evidence for the communicative role of
cytokines between neuroendocrine and immune systems. Since the adrenal medulla is
of neural crest origin, expression of cytokine receptors on medullary chromaffin cells is
quite likely.

IV.

Possible Role of Cytokines in the CA Secretion from Adrenal Medulla.
The existence of signals originating from the immune system to bring about

neuroendocrine response has only recently begun to be evaluated. No work has been
reported that examines the potential action of cytokines to influence adrenal medullary
CA secretion. One single report indicates that IL-1 stimulated corticosterone release
occurs through the local CA outflow from the rat adrenal gland (A.R.Gwosdow, et al.
Abstract, FASEB meeting 1992). This work suggests that IL-1 can cause CA secretion
from chromaffin cells. In contrast, numerous investigations have been conducted to
assess the impact of CA on immunological activities [10]. Spengler, et al. (1990) have
demonstrated that a-2 adrenergic agonist can augment LPS-stimulated TNF from elicited
macrophage [106]. The increase in TNF production was concentration-dependent. The
presence of a macrophage a-adrenergic receptor was detected by binding of the specific
antagonist 3H-yohimbine. These investigations reveal the role of CA that may regulate
cytokine production during an inflammatory response. Conversely, cytokines may carry
messages in the opposite direction by acting on the sympathoadrenal system.
Receptors for growth hormone share large degree of homology with cytokine
receptors, especially within the extracellular sequence [107]. IGFl (Insulin-like growth
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factor 1) receptor is present on bovine chromaffin cells [108].

It is possible that

cytokines may influence the secretion of adrenal chromaffin cells through either IGFl
receptors or more specifically through cytokine receptors if they were actually there.
The complete signaling loop between immune and sympathoadrenal systems is
anticipated. There is evidence that the immune-HPA axis regulatory loop is not the only
one involving cross system interactions [12]. The communicating circuit between the two
systems might possibly be complemented by immune-derived products, cytokines for
instance, acting on the sympathoadrenal end.
Under physiological conditions, CA is contained in the membrane-bound vesicles
beneath the plasma membrane and is released through exocytosis following nicotinic
and/or muscarinic activation. Nicotinic stimulation results in the influx of cation through
ion pore within the receptor itself which then depolarizes the cell. Voltage-dependent
Na+ and Ca2 + channels are opened by depolarization. Exocytosis occurs immediately
after the rise of [CA2 +l due to Ca2 + entry and calcium-induced calcium release from
internal stores. Muscarinic stimulation leads to the production of IP3 which mobilizes
Ca2+ from intracellular Ca2 + pools. Calcium from IP3-sensitive pool does not appear to
trigger exocytosis in most species. In resting cells, chromaffin granules are bound within
a cytoskeletal matrix and are unable to reach the secretory sites.

Cortical actin

cytoskeleton plays a role in the control of exocytosis by acting as a barrier to secretory
granule movement. Disassembly of the cytoskeleton net is necessary, but not sufficient,
for a full secretory response. Calcium and/or protein kinase C are involved in bringing
about actin disassembly/reorganization, but the exact mechanism is unclear. Several
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actin-regulatory proteins that are possible targets for the action of Ca2 + and PKC are
present in chromaffin cells. Calcium entry and the subsequent rise of [Ca2+]; is essential
and sufficient for exocytosis, whereas PKC is able to modulate this process by
controlling Ca2 +-sensitivity [24]. As aforementioned, the activation of cytok:ine receptors
may be associated with increases of intracellular calcium levels and protein kinase C
activity. Cytokines would be capable of activating the intracellular signals that lead to
exocytosis if cytokine receptors existed on chromaffin cells.
Cytok:ine production is a dramatic whole-body response when immune components
are confronted with bacterial insult. Non-neurogenic CA output from adrenal medulla
may be an important component of the sympathetic response to sepsis but mediators
causing this release are unknown. Based on the knowledge reviewed above, cytok:ines
may play a role in stimulating CA secretion of adrenal chromaffin cells. This thesis
project examines this possibility through an initial set of experiments involving immunederived factors that are applied to chromaffin cells in vitro.

METHODS

I.

Bovine Chromaffin Cell Isolation and Culture.
Adult bovine adrenal glands obtained from a local supplier are kept in room

temperature buffer during transportation to the laboratory. Glands are trimmed of fat and
rinsed through the adrenal vein with Ca2 + - and Mg 2 + -free buffer to remove all blood.
Cell isolation is achieved by 0.17% collagenase P (Boehringer Mannheim Biochemicals)
digestion (basic procedure by Fenwick et al [109], modified by Greenberg and Zinder
[110]). Three to five milliliters of freshly prepared collagenase solution is infused
through the adrenal vein followed by incubation of the gland in additional collagenase at
37 °C for 15 min. This step is repeated. The gland is then cut in half sagittally and the
medullary contents are removed with forceps, minced and rinsed through 200 µm nylon
mesh with additional buffer. The isolated cells are rinsed to remove collagenase and
saved in buffer at 37 °C. Tissue remaining on the mesh is incubated for 30 min with
additional collagenase containing DNAse followed by filtration through clean mesh and
removal of collagenase. All chromaffin cells are combined and layered onto a 1: 1
mixture of complete Lockes solution and fetal calf serum for density gradient
centrifugation [111]. Following low speed (50 x g) centrifugation, cells are resuspended

in complete Lockes solution and the density purification repeated. Determination of
viability and purity is achieved by using trypan blue exclusion and neutral red staining,
respectively. Cells are counted in a hemacytometer.
Cells are plated on collagen-coated 24-well plates at a density of 6 x 105 cells per
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2 cm 2 in 1 ml culture media. The media contains a 1: 1 mixture of Dulbecco's modified
Eagle medium and F12 supplemented by 10% fetal calf serum, 9 mM HEPES, 3.2 mM
glucose, 2 mM glutamine, 100 µg/ml penicillin G, 20 µg/ml gentamicin, 50 U/ml
nystatin, 2.4 µg/ml 5-FDU and 2.8 µg/ml Ara-C. The media is changed the next day and
then every other day. Cells are maintained at 37 °C in a humidified atmosphere
containing 5 % C02 •

Il.

Preparation of Conditioned Media.

1) Isolation of bovine spleen cells:
Bovine spleen is obtained from a local supplier and brought to the laboratory at
room temperature. Several tissue pieces are excised from interior of the organ. Cells are
dispersed by pushing them through a 520 µm stainless steel mesh in Hank's solution with
a plunger from 30 ml syringe. The cell suspension is diluted with Hank's, layered over
a Lymphocyte Separation Medium (LSM, Ficoll, Organon Teknika), and centrifuged at
400 x g for 30 min. Lymphocytes and other mononuclear cells (platelets and monocytes)
move to the Hank's-LSM interface, and are then recovered by aspirating the layer. The
recovered cells are washed twice in Hank's media and centrifuged at 210 x g for 10 min.
The cells are finally resuspended in 10 ml RPMI 1640 culture media.
2) PHA conditioned culture:
The lymphocytes are cultured at a concentration of 1-2 x 106cells/ml in RPMI
1640 supplemented with 10% FCS (heat inactivated), MEM non-essential amino acids,
4 mM Glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin. They are incubated
with or without 0.5 % phytohemagglutinin (PHA) for 24 hr in 5 % C02 atmosphere at 37
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°C. The conditioned media is then separated from the cells and saved in -20 °C freezer
for future experiments.

m.

Experimental Protocol.

1l Functional Characterization:
Chromaffin cells are maintained for 3 different periods (1, 4 and 8 days) prior to
secretion experiments. Typically, serum containing media is discarded and replaced by
Earle's balanced salts solution (EBSS) which is supplemented with 25 mM HEPES, 0.1
mM EDTA and 1.8 mM Ca2 +. Incubation in EBSS (0.5 ml/well) is maintained for 30
min. at 37 °C, then the media is removed, chilled, centrifuged and acidified with HC104
to a final concentration of 0.4 Mand 0.1 mM EDTA. The samples are kept at -70 °C
for later determination of catecholamines. Catecholamine content in these samples
represents spontaneous (corresponding to 'non-neurogenic' in vivo) release during the 30
min. incubation period. Immediately following removal of EBSS, the cells are exposed
to nicotinic agonist DMPP (dimethylphenylpiperazinium) at 0, 1, 5 or 10 µMin EBSS.
After 10 min., the secretagogue-containing media is removed and processed as before.
Each well is then flooded with 1.0 M HC104 with 0.1 mM EDTA and this is used to
determine the remaining catecholamine content of the cells.
2) Experiments with PHA conditioned media:
The experiments are carried out 3 or 4 days after chromaffin cell isolation.
(i) Effect of PHA conditioned media on CA secretion from BCC: BCC are incubated
with supplemented RPMI 1640 either with or without addition of PHA, or splenocyte
culture media either with or without PHA stimulation. After 90-min incubation, the
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supernatants are removed and saved, and chromaffin cells are then exposed to 3 µM
DMPP for 10 minutes in the presence of corresponding media used during previous
incubation.
(ii) Dose-dependent effect of PHA conditioned media: After removal of BCC culture
media, the cells are incubated with different dilutions of conditioned media (1 :99, 1:9,
1:1 in supplemented RPMI 1640, and full strength) at 37 °C for 90 min. Samples are
then collected and saved. Immediately after this incubation, cells are exposed to 3 µM
DMPP for 10 min. DMPP is dissolved in the corresponding preincubation media.
(iii) Time-dependent effect of PHA conditioned media: Cells are incubated with full
strength conditioned extract for different times (10, 30, 60, 90, 150, 210 min) followed
by 10 min DMPP stimulation at 3 µM. Supernatants are collected before and after DMPP
stimulation.
3) Test of Exocytotic Activity vs Leakiness:

Chromaffin cells are incubated with PHA conditioned media, splenocyte culture
media without PHA stimulation, fresh RPMI 1640 media with or without addition of
PHA, DMPP (in RPMI 1640), or 20 µM Digitonin at 37 °C for 90 min. The
supernatants are then collected and saved for LDH assay. Samples digitoninpermeabilized cells which leak LDH into the media are used as positive experimental
control.
All experiments of this project are conducted using triplicate samples for each
condition, and repeated on at least 3 different chromaffin cell preparations.

IV.

Catecholamine Assay.
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Secretion of epinephrine and norepinephrine is determined by HPLC

with

electrochemical detection. HPLC mobile phase consists of 0.1 M monochloroacetic acid,
1 mM sodium octyl sulfate, 0.5 mM Nai-EDTA, and 1.5% acetonitrile at pH 3.0. The
column is a 10 cm OSD Biophase II (BAS, West Lafayette, IN), and the working
electrode is glassy carbon with a model LC-4B amperometric detector (BAS). Before the
assay, the samples are filtered through nylon membrane with 0.22 µm pore size.

V.

Lactate Dehydrogenase Assay.

LDH is measured by monitoring the formation of NADH from NAD at 340 nm with
spectrophotometer. LDH was determined with the generous cooperation of Clinical
Chemistry of LUMC.

VI.

Statistics.

The basic test statistic used was an one-way analysis of variances (ANOVA). Significant
differences indicated by ANOVA were followed by Newman-Kuels test for individual
comparisons.
Data from BCC characterization underwent transformation and was shown to be normally
distributed. The effect of dose and time was tested with two-way ANOV A followed by
Tucky's test for individual comparison.

RESULTS

I. Characterization of Isolated Bovine Chromafrm Cells in Primary Culture.
The quality of bovine chromaffin cell (BCC) preparations was indicated by the
viability and purity of the isolated cells (Table 1), which were detected with trypan blue
exclusion and neutral red stain respectively.

Typically, 50-100 million cells were

harvested from one adrenal gland with the variation most likely linked to the gland size.
The percentage of viable cells was consistently high (93

± 2 %), while the purity ranged

at 90-95 % in 15 out of 18 preparations.
In order to characterize functional changes of cultured BCC over time, cultures
were maintained for 1, 4 or 8 days before the secretion response to DMPP (nicotinic
agonist) was tested. Cells were stimulated with 1, 5 and 10 µM DMPP for 10 minutes.
In Figure 1, catecholamine (CA) secretion was expressed as the absolute amount from
each well, containing 600,000 cells. Between 1-5 µM, there is over a five fold increase
in response to the agonist. There was no significant increase of secretion when the dose
was raised from 5 to 10 µM. At the level of 10 µM DMPP, saturation started to occur
and was confirmed with higher concentrations (data not shown). There was significant
interaction between dose (DMPP) and time (days in culture) effects for both Epi and NE
secretion. This suggests that the culture duration influences the dose-response relation
of nicotinic-mediated secretion. It appeared that the longer the cells had been cultured,
the more responsive they were to nicotinic stimulation. The differences were apparent
when comparisons were made between 8- or 4-day vs 1-day groups. Statistical analysis
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confirmed the differences with different culture durations at 1 µM DMPP for both Epi
and NE secretion.

The overall effect of culture duration on combined Epi and NE

secretion irrespective to DMPP concentration were significant between 8- or 4-day vs 1day, though there was no interaction. This indicates that the curves of the combined Epi
and NE secretion are shifted parallel to the left.
To correct for the possible variations between BCC preparations and differences
in the number of cells in different wells, catecholamine secretion from each well was
normalized to its own total cellular content. In Figure 2, the percentage of total Epi, NE
or both, released in response to DMPP, is displayed. The pattern of dose-response curves
is very similar to that in Figure 1, while the apparent change across time appears more
obvious. The overall effect of culture duration on percent CA secretion is significant
between 8- or 4-day vs 1-day regardless of DMPP concentration. After BCC had been
cultured for several days, 5 µM DMPP induced up to 17% secretion of NE and 12 % of
Epi, whereas only 5-6 % was induced by 5 µM one day after isolation.

The cells

underwent a bigger change during the first four days in culture than they did in the
second four days. Within the dose range examined, the maximal release evoked by 10

µM DMPP was around 15% for epi and 20% for NE.
Total cellular CA content are also compared between cells maintained in culture
for varying durations (Figure 3). The total catecholamine content stores in each well
decreased over time. Epi content counted for roughly 75 % of CA storage in chromaffin
cells. The greatest decrease of Epi was seen during the initial four days (15 % of initial
content) and there was a 20% drop after eight days in culture. Statistical differences in
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TABLE 1

SUMMARY OF BCC PREPARATIONS
HARVEST

VIABILITY

PURITY

(10 6 cells)

(%)

(%)

60

93.5

90

48

96

94

4/14/92

75

95

85

3/30/92

80

95

91

3123192

48.5

95.5

91.5

319192

85

92

91.5

2/27/92

100

91.6

73

2/13/92

93.5

90.5

92.7

213192

78

92

94.4

33.4

93.5

90.6

88.5

95

92

1116/92

41

91

91

12119/91

90

91.2

91

12/5/91

61.8

94

83

11/21191

61.6

89

89.6

11114/91

20

93

92

11/11191

110

98

94

10/31191

90

90

95

MEAN

93.3

91.7

SD

2.28

4.18

DATE

517192

1123/92

BCC: Bovine Chromaffin Cells
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Figure 1. Changes in DMPP-mediated CA secretion over time in culture. BCC were
exposed to 0, 1, 5 and 10 µM DMPP after 1, 4 or 8 days in culture. For each dosage,
secretion was determined in triplicate wells. The same protocol was repeated with four
different adrenal glands (N =4). The data points are means + SEM. Significant
differences exist between 10 or 5 vs 1 µM DMPP in all plots (not marked). *, P < 0.05
for 8- or 4-day vs 1-day at that dose. The overall means of Epi&NE secretion at 8- or
4-day are significantly different from 1-day irrespective of DMPP concentration (P <
0.05, not marked).
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Figure 2. Changes in DMPP-mediated CA secretion over culture time. The secretion
data shown in Fig-1 was normalized to the corresponding total cellular content, i.e.,
secretion was expressed as % of initial total. The overall means of 10 or 5 µM are
significantly different from 1 µM irrespective of time (P < 0.05, not marked). The
overall effect of culture duration is significant betwee 8- or 4-day vs 1-day irrespective
of dose(#, P < 0.05).
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Change of Total Cellular CA Content
with Culture Duration
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Figure 3. Changes of cellular catecholamine content over time in culture. Total NE,
Epi and combined NE&Epi contents were measured 1, 4 or 8 days after cell isolation.
Values are Means + SEM. Four triplicate determinations were made in each of four
BCC preparations (N=4).
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Epi or combined Epi and NE could only be detected between 8- and 1-day. In general,
total CA content was 13,000 - 16,000 ng/0.6 x 106 cells.

Based on changes in the

functional characteristics, all the following experiments were conducted on 3-5 days old
BCC.

II. Effect of the Culture Media from PHA-stimulated Splenocytes on CA Secretion
Mononuclear cells, which include Band T lymphocytes, monocytes/macrophages
and platelets, were isolated from bovine spleen and cultured in the presence (StimExtract) or absence (NonStim-Extract) of 0.5 % (v/v) FHA. After 24 hours, the culture
supernatants were collected.

Chromaffin cells, incubated with the FHA-conditioned

media for 90 minutes, released over 20 % each of their Epi or NE content which is 4-5
fold more than that of the control groups (Figure 4).

In contrast to the secretory

response to nicotinic agonist, this conditioned media induced slightly more Epi release
than NE in terms of percent secretion. The FHA-conditioned media exerted its effect in
a concentration-dependent manner (Figure 5).

One to one dilution of the original

supernatant induced a secretion response at about half of the maximal magnitude, which
was still a statistically significant increase as compared to that of the group treated with
non-stimulated extract.
FHA-conditioned media not only caused the CA release of chromaffin cells, but
also enhanced the secretion resulting from nicotinic activation. Immediately after the
first 90-minute incubation with different media, the cells were exposed to DMPP. As
demonstrated in Figure 6, 3 µM DMFF in control media brought about 3-4 % secretion
of Epi or NE during a 10-minute incubation, while the same concentration of DMPP in
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Effect of PHA Condition Media
on CA Secretion
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Figure 4. Effect of conditioned-media on CA secretion. After 3-5 days in culture,
chromaffin cells were treated with supernatants from 24-hour splenocyte cultures with
or without PHA stimulation, and fresh RPMI 1640 with or without addition of PHA.
After 90 minutes, media was collected and saved for NE and Epi assay. Two spleen
preparations (N =2) were tested with four BCC preparations (N =4). Each condition was
performed in a triplicate. *, P < 0.05 compared to all the other groups.
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Dose-Response Relationship
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PHA Conditioned Media
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Figure 5. Concentration-dependent effect of conditioned media on Epi secretion.
Different dilutions of PHA-conditioned media were tested on chromaffin cells with 90min incubation. The concentrations were 1:99 (0.01), 1:9 (0.1), 1:1 (0.5) and full
strength (1.0). *, P < 0.05 fort-test comparison between Stirn- vs NonStim- Extract.
#, P < 0.05 for individual comparisons following ANOVA of Stim-Extr across dilutions;
marked points are significantly different from those at any other dilutions. Two
splenocyte (N =2) and
four BCC (N =4) preparations were used. Triplicate
determinations for each condition.
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Effect of PHA Conditioned Media
on DMPP-induced Secretion
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-

Epi

*

Figure 6. Effect of conditioned media on DMPP-mediated CA secretion. Immediately
following the 90-min incubation with various media, chromaffi.n cells were stimulated
with 3 µM DMPP in the presence of corresponding incubation media for 10 minutes. CA
secretion from cells treated with PHA conditioned media was significantly enhanced in
comparison to all the others (*P < 0. 05).
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Figure 7. Concentration-dependent effect of conditioned media on DMPP-induced Bpi
secretion. Following 90-min exposure to different dilutions of conditioned media, Bpi
secretion in response to 3 µM DMPP were examined in the presence of corresponding
different dilutions of conditioned media. *, P < 0.05, t-test comparison between NonStim and Stirn Extracts at each dilution.#, P < 0.05 for individual comparison following
ANOVA of Stim-Extr across dilutions; significant differences are present between 1.0
or 0.5 vs 0.1 or 0.01.
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the presence of PHA-conditioned media doubled the release.

This enhancement of

DMPP-stimulated secretion was also concentration-dependent (Figure 7).

Statistical

differences across different dilutions of conditioned media occurred between any two
concentrations except between 0.1 vs 0.01.
Figure 8 contains the results of the time course of Epi secretion in response to
PHA-conditioned extract. Six different incubation times ranging from 10 to 210 minutes
were examined. Within the first 60 minutes, Epi was released to the media at a higher
rate than that during the later phase. There was a transient plateau between 60 to 90
minutes, then chromaffin cells continued to secrete at a relatively constant rate during the
2 hours after the initial 90-minute period. NE secretion also followed the similar pattern
(data not shown). At the end of 210-minute, up to 30% of the cellular Epi storage was
secreted. To examine if pre-incubation duration effects the DMPP evoked secretion, the
chromaffin cells were stimulated with 3 µM DMPP in the presence of conditioned media
after they had been incubated for various times as described above. No matter how long
the cells were pretreated with the extract of PHA activated splenocytes, the following
DMPP stimulation was not affected.
Results of the nine splenocyte preparations are summarized in Table 2. The
potency of the conditioned media from these mitogen-stimulated cells was variable. Four
preparations were relatively more potent than the others in terms of their ability to cause
CA release. The difference in CA response between extracts from the cultures with or
without PHA stimulation was demonstrated in only one of the spleen preparations.
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TIME DEPENDENT EFFECT
OF PHA CONDITIONED MEDIA

30
25+
20
15

~

10

~

5
O-t-~-+~~-+-~~+-~-1-~~-+-~~1--~--+~----I

0

30

60
90
120
150
180
210
Time of incubation with CM (min)

240

Figure 8. Time course of the effect of PHA CM on Epi secretion. Different times of
chromaffin cell incubation with PHA CM were followed by 3 µM DMPP stimulation for
10-min. Statistical differences exist between any two data points except between 90' and
60' (P < 0.05, not marked). Triplicate determinations. BCC, N=5; spleen, N=4.
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TABLE2
RESPONSE OF BCC TO CONDmONED MEDIA
DATE
(spleen
preparation)

Viability

Purity

(%)

(%)

Age
(day)

Non-Stirn.
1st.

98

94

10' 3uM DMPP

90' secretion
PHA-Stim.
11.2

5.5*

4

10.4

5.2*
4.7•

4.3*

7.6

4.5•

4.7*

11

11.3

7.3*

5.9*

89

89.6

l

7.8

8.4

3rd.

94

83.5

l

13

10

4

16.3

15.3

l

8.5

4
5th.
112/92

6th.
2/20/92

7th.

90

91

91

91

4

5.7

20.l

3.3

6.1

93.5

91

3

5.1

18.3

3.3

4.5

95

92

4

5.9

18.9

3.4

6.3

92

94.4

4

90.5

92.7

4

4.1

12.l

3.3

5.4

91.6

73

3

8.0

7.1

3.6

3.5

4

7.0

6.3

4.3

4.0

3

6.5

5.0

4.6

4.4

5

16.9

16.7(M)

4.4

4.0(M)

92

91.5

8th.
3/13/92

6.7

16.6

4.S(W)

21.S(W)

9th.
3/30/92

PHA-Stim.

l

2nd.

4th.
12113/91

Non-Stirn.

95

91

3

12.4(\V)

14.2

4.2

4.0

14.2

13.2

3.5

3.6

13.8

14.3

8.1

6.1

• : stimulation with 10 µM DMPP.
M and W stand for two different preparations of supplimented RPM! 1640 medium, i.e., made by Dr. Matthews and Z. Wang
respectively. 2-ME is 2-mercaptoethanol. l-2FCS is the fetal calf serum used on Jan 2, 1992.
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LDH in Bovine Chromaffin Cell Media
Following Incubation with Condtioned Media
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Figure 9. LDH in BCC media following incubation with splenocyte conditioned
media. Chromaffin cells were incubated with PHA CM, fresh RPMI 1640 culture
medium, 3 or 10 µM DMPP, and 20 µM Digitonin for 90 minutes. The supernatants
were then collected for LDH assay. Each bar is mean ± SE. Triplicate determination for
each treatment. PHA CM from four spleen preparations were tested on three BCC
isolations. Six different combinations (N=6) of PHA CM and BCC were used for the
group of PHA CM; N =3 for all the contols. *, significant difference compared to all the
other groups at P < 0.05.
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ID. Detection of Cell Membrane Integrity by LDH Assay.
Lactate dehydrogenase (LDH) normally exists in cytoplasm. LDH concentration
in culture supernatant was estimated to confirm that the cells maintained their membrane
integrity when they were exposed to different testing media.

There was no real

difference between the groups treated with lymphocyte culture medium, 3 or 10 µM
DMPP and PHA conditioned splenocyte medium (Figure 9). Digitonin is a detergent that
can render the cell membrane leaky to LDH and is applied as a positive control agent.
Digitonin-treated cells released much more LDH than all the other groups.

DISCUSSION

The chromaffin cells of bovine origin (BCC) have been extensively used in the
studies of endocrine mechanisms, neuronal function and basic cell biology of the
secretory process [112, 113]. It is a particular advantage that they can be isolated in large
quantities to provide a relatively homogeneous cell population. The primary culture of
BCC can usually be maintained for up to 10 days, but the cells change morphologically
and functionally during time in culture.

Owing to this concern, functional

characterization, especially of the secretory change with culture age, must be established
prior to experiments with this in vitro model.
In bovine species, nicotinic activation of chromaffin cells is the physiological
stimulus leading to CA secretion, whereas muscarinic activation is not sufficient to
trigger exocytosis [24, 114]. DMPP (Dimethylphynylpiperazinium), a synthetic nicotinic
agonist, was used to mimic "neurogenic" secretion in vitro, because adrenal medullary
CA output in vivo is mediated by nicotinic activation by acetylcholine, released from
preganglionic nerve endings. The dose-response relationship was examined on BCC of
four different adrenal glands. As the culture duration gets longer (1, 4 and 8 days), the
secretory response seems to become larger for the same concentration range. Changes
were more obvious in the first four days (Figures 1, 2). There are at least three possible
explanations for this phenomenon. One is that membrane proteins of the chromaffin cells
may be damaged by the collagenase digestion procedure of cell isolation. The initial
increase in response to DMPP could be due to the recovery of nicotinic receptors on cell
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membrane. The second explanation is that there is a functional shift from muscarinic- to
nicotinic- cholinergic receptors during the primary culture of BCC. This finding has been
reported by Nakaki et al [115] who observed that in less than 2 days of primary culture,
muscarinic but not nicotinic stimulation leads to IP3 (inositol triphosphate) formation and
calcium mobilization, whereas at periods longer than 4 days, the opposite occurs.
Thirdly, the sensitivity to nicotinic agonist may be increased after a period of time of
culture. This could be the result of an alteration in any event of stimulus-secretion
coupling. Therefore, it is important that chromaffin cells be cultured for a consistent
duration before secretion experiments are conducted, to ensure appropriate comparison.
The CA content was indicated to decline over time in culture (Figure 3). Fifteen
to 20 % reduction was observed after 4-8 days in culture. Epi content accounted for
about 75 % of the total CA, and the Epi drop reflected a loss of apparent storage without
any significant changes of NE content. Similar observations have been reported by other
groups [114, 116]. This result may be interpreted in two ways: either by a selective death
of Epi-storing cells or by a decrease of PNMT (phenylethanolamine N-methyltransferase)
activity in former Epi synthesizing cells. Since the activity of PNMT is regulated by the
pituitary-adrenocortical axis, it has been proposed that the lack of functioning adrenal
cortical tissue in BCC cultures accounts for the decrease in Epi-forming capacity [114].
However, BCC treated with dexamethasone failed to alter cellular CA levels [117].
Glucocorticoids may have a permissive effect rather than a positive one, but the
mechanism and the relevance of this phenomenon are poorly understood. In general, the
characteristics of in vitro BCC model revealed in the present experiments are in good
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agreement with the observations by other laboratories. These include the high viability
and purity of the BCC preparations, the percentage of secretion in response to nicotinic
agonist, and the change in expression of nicotinic vs muscarinic receptors with culture
time.
Studies with adrenal chromaffin cells in culture have been particularly valuable
in elucidating postsynaptic events involved in stimulus-secretion coupling and in
suggesting mechanisms that may operate in vivo to control secretion from adrenal
medulla. Previous findings in whole animal models demonstrate the existence of nonneurogenic CA release in endotoxic states [5, 6]. Elucidation of potential mediators
responsible for stimulating chromaffin cell secretion would be facilitated by using in vitro
model systems.
The objective of this project was to assess the role of immune-derived factors,
such as cytokines, in mediating the CA secretion from adrenal chromaffin cells. The
experimental approach to accomplish this goal involved the following:
1) A potent inducer of cytokine production is needed to obtain a broad spectrum of
cytokine. Phytohaemagglutinin (PHA), a mitogenic lectin from red kidney beans, is a
widely used polyclonal stimulant of lymphocytes. PHA exerts its mitogenic effect through
the induction of cytokines. In contrast to stimulation by antigens, in which specific clones
of lymphocytes are activated, PHA can motivate multiple clones irrespective of their
antigen specificity, so that the percentage of responding cells is 70-80 % of the
lymphocyte population [118]. The activated cells release a variety of cytokines which
have pleiotropic activity and are able to regulate cell growth and differentiation. IL-2
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(originally known as T-cell growth factor) and IFN'Y are the best characterized among
them. IL-2 is required for the proliferation of activated T cells [119]. Meanwhile, IL-2
can result in the production of IFN1 in spleen cells [120]. TNFa is the main cytokine
produced by IFN,,-activated macrophages [121]. In addition, activated-macrophages
secrete IL-1, which is necessary for the production and release of IL-2 [122].
2) One easily obtainable source of immune cells from the same species as chromaffin
cells is the bovine spleen. A mononuclear cell population, predominantly including B and
T lymphocytes, monocytes/macrophages, and some platelets, was prepared from bovine
spleen. After isolation, they were then stimulated with PHA and cultured for 24 hours.
Cell proliferation is an indication of cytokine release because most of the cytokines are
pleiotropic. The cell-free supernatant of this culture (referred as PHA-conditioned media)
is considered to contain various cytokines and other soluble factors released by PHAactivated splenocytes.
3) To determine the potential role of immune-derived factors, presumably cytokines, on
CA secretion from adrenal medulla, the cytokine-rich supernatant was placed on bovine
chromaffin cells in primary culture and CA secretion was measured.
As illustrated in Figure 4, the PHA-conditioned media did affect CA secretion
remarkably, with a 4-5 fold increase over the controls after 90 minutes. Not only did it
stimulate CA release by its own, it also enhanced the nicotinic secretion (Figure 6). Both
responses exhibited concentration-dependency (Figure 5, 7). However, the potency of the
conditioned media was variable. Four out of nine splenocyte preparations were relatively
more potent than the others in terms of their ability to cause CA release. The difference
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in BCC secretary response between extracts from the cultures with or without PHA

stimulation was demonstrated in only one of the spleen preparations. Several components
of the lymphocytes culture medium, such as fetal calf serum, 2-mercaptoethanol and Lglutamine, which might have big influence on splenocyte culture, were ruled out. The
other possibility is that these spleen-originated mononuclear cells may have been already
activated if they have exposed to certain antigen in vivo. For instance, domestic cattle
(which the spleens were obtained from) are usually given double stranded RNA
(structurally similar to RNA virus) to prevent them from viral infection. The strategy of
this treatment is to induce the production of IFN which has antiviral activity. In addition,
the cell isolation procedure itself and the serum-containing culture medium may also
serve as stimuli to these immune-participating cells.
In the course of 210-minute incubation with FHA-conditioned media, almost onethird of CA store was released into the media (Figure 8). It seems that this elevation of
secretory response is sustained and lasts for as long as four hours. If these results
reflected the situations in vivo, it would provide an explanation to the non-neurogenic CA
outflow from adrenal medulla following immune response to LPS.
To examine the nature of this CA release, LDH (lactate dehydrogenase) activity
in the media was estimated. Because LDH is a cytosolic enzyme, its release is an
indication of cell membrane disruption. Some detergents, such as digitonin, can make the
cell membrane permeable to cytosolic molecules with MW less than 1000 kD including
LDH. Digitonin has therefore been used as a positive control of plasma membrane
leakiness [123]. Although the LDH level of PHA-conditioned media-treated group
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appeared slightly higher than the negative controls, it was much lower than that of
detergent-treated groups. There was no significant release of LDH above basal level
when the cells were exposed to either DMPP or PHA-conditioned media. The integrity
of BCC membrane appeared intact, while CA release through exocytosis instead of cell
lysis is implied. Ion analysis of the splenocyte supernatant excluded the possibility of
potassium elevation. The direct effect of PHA by itself was eliminated by measuring CA
released in the presence of PHA alone. Taken together these findings imply that the
soluble products derived from the activated immune cells may serve as stimuli to cause
exocytosis in chromaffin cells.
Despite the fact that the precise contents in this conditioned media has not been
clarified, information about cytokine receptors and the cellular mechanisms of cytokine
action supports the possibility that cytokines may influence chromaffin cell secretion. As
previously reviewed, cytokines transmit their biological signals to specific cells within
hematopoietic, lymphoid as well as other organ systems via interaction with specific cellsurface receptors. Cytokines and their receptors play a key role in the communication
between neuroendocrine and immune systems [71, 75, 76]. For instance, IL-1 and IL-2
receptors were expressed on pituitary cells and other areas of the brain in animals and
human [95, 96, 97, 98, 99]. Virtually all nucleated cells within a species are sensitive
to IFN of that species and presumably possess IFN receptors [101]. It is unknown if
certain cytokine receptors exist on chromaffin cell membranes. To date, there is only one
report indicating that IL-1 stimulates corticosterone release indirectly through the action
of local CA outflow which is also induced by IL-1 in rat (A.R. Gwosdow, et al.
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Abstract, FASEB meeting 1992). Nonetheless, BCC was revealed to express a number
of different receptors including IGFl receptor in addition to the nicotinic and muscarinic.
IGFl has been shown to have a stimulatory effect on CA release from chromaffin cells
[108]. Growth hormone receptors share a large degree of homology with cytokine
receptors, especially in the extracellular sequence [107]. It is possible that cytokines
effect CA secretion via binding to the IGFl receptors.
The intracellular events associated with cytokine receptor activation usually
include calcium elevation and increased protein kinase activity. For example, calcium
influx has been observed on cells exposed to IFN-y, and the combination of a PKC
activator and a calcium ionophore induced many of the same cellular responses as IFN-y
[68, 69, 70]. Protein kinase may also be involved in signal transduction of TNFa, IL-1
and IL-6 [63, 64, 65]. Coincidentally, calcium entry and the subsequent [Ca2 +]i rise is
essential and sufficient for exocytosis in chromaffin cells, whereas PKC is able to
modulate stimulus-secretion coupling by controlling Ca2 +-sensitivity [24]. If the BCC
express such cytokine receptors as IFN-y receptor, it is likely predicted that IFN-y can
alter CA secretion since it shares the same intracellular messengers as those normally
triggering exocytosis in chromaffin cells. CA release caused by the cytokine-rich media
could possibly result from the calcium entry through an unidentified channel which might
be activated by ligand-receptor binding.
The enhancement of nicotinic secretion may be explained by the involvement of
PKC. Calcium and/or PKC can in some way disassemble/reorganize the actin network
and consequently potentiate the secretory response by freeing more NE or Epi granules,
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which are normally fixed within an actin cytoskeleton matrix.
Although results of the present study do not examine specific effect of cytokines,
cytokine action on CA secretion from adrenal medullary cells is inferred. The
physiological implication of these findings lies in the interrelationship of immune
response and catecholamine action. Numerous studies have been conducted to assess the
impact of CA on immune function. NE and Epi may alter immune response through
modulation of such functions as cellular migration, lymphocyte proliferation, antibody
secretion, or cell lysis [124]. Both

a-

and /3-adrenergic receptors are found on

lymphocytes and accessory cells in human and other species. In particular, IL-2 synthesis
by human T-cell line were shown to be inhibited following stimulation of /3-adrenoceptors
[125]. The presence of primarily /3 2-adrenoceptors on lymphocytes suggests that Epi may
be more influential than NE in altering lymphocyte function [126, 127, 128]. The major
source of Epi is adrenal medulla of which the hormonal output delivers messages to the
body immune section.
In a physiological model, potential communication from the immune system to
the sympathoadrenal system is likely to occur. Such information flow could be
accomplished by soluble mediators (e.g. cytokines) secreted from immunocompetent
cells, which influence local or distal neural or endocrine targets. Based on previous
studies and present results, a feedback circuit can be pictured for in vivo reciprocal
regulation of immune-sympathoadrenal function. If immune system is viewed as a sensor
of foreign invasions, it then likely passes the signal to all of its cooperative organs via
molecules produced by the activated immune cells. The observations of the present
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investigation demonstrate that the adrenal medullary chromaffin cells respond to these
immune-derived signal molecules by releasing more CA into circulation. Since the
immunocompetent cells bear adrenoceptors, CA may exert their cooperative effort to fine
tune the immune response to any insults. As a feedback signal, CA is capable of down
regulating lymphocyte activity after earlier activation. For example, later events in an
immune response such as continued cell proliferation, antibody secretion, and cytotoxic
T lymphocyte-mediated lysis are inhibited by jJ-adrenoceptor stimulation and cAMP
elevation [129]. Consequently, the modulation by CA ensures that the magnitude of
immune response is roughly proportional to the amount of antigen encountered and the
ongoing response is appropriately terminated. At this point, the regulatory loop between
immune organs and adrenal medullum is completed.

SUMMARY

I.

Immune-derived products from mitogen-treated splenocytes stimulate EPI and NE
secretion from cultured bovine chromaffin cells, and enhance the nicotinic agonist
induced release.

II.

The CA release induced by immune-derived factors is not due to the damage of
cell membrane. Alternatively, these results suggest that exocytosis is triggered
when cells are exposed to the media of mitogen-stimulated splenocyte culture.

ill.

Specific factors that are responsible for stimulating CA secretion from BCC
remain to be investigated.
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